Search

Your search keyword '"Trimble, Johanna"' showing total 38 results
Start Over Author "Trimble, Johanna"
38 results on '"Trimble, Johanna"'

5. Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Published
2023
Full Text
View/download PDF

6. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks

Author

McDonald, Emily G., primary, Lundby, Carina, additional, Thompson, Wade, additional, Boyd, Cynthia, additional, Farrell, Barbara, additional, Gagnon, Camille, additional, Herbin, Jennie, additional, Khuong, Ninh, additional, Moriarty, Frank, additional, Pierson, Tiphaine, additional, Scott, Sion, additional, Scott, Ian A., additional, Silvius, Jim, additional, Spinewine, Anne, additional, Steinman, Michael A., additional, Tannenbaum, Cara, additional, Trimble, Johanna, additional, Turner, Justin P., additional, and Reeve, Emily, additional

Published
2024
Full Text
View/download PDF

8. Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Freeman, Karla, additional, Ali, Abbas, additional, Clark, Rebecca, additional, Shah, Nikki, additional, Awan, Amen, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Dore Brown, Naomi, additional, Jurcic-Vrataric, Jane, additional, Colwill, Kiska, additional, Dragos, Steven, additional, Borhan, Sayem, additional, Risdon, Cathy, additional, Siu, Henry, additional, Farrell, Barbara, additional, and Trimble, Johanna, additional

Published
2023
Full Text
View/download PDF

9. sj-docx-3-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-3-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

10. Additional file 2 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 2. Consort extension for pilot and feasibility trials checklist.

Published
2023
Full Text
View/download PDF

11. Additional file 4 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 4: Results of patient outcome measures. Fig. 3. EQD5 and SF36-V1 quality of life scales. Fig. 4. WHODAS, psychological distress, mobility fatigue, sleep quality. Fig. 5. Patient enablement, cognition, and nutrition. Fig. 6. Number of medications. Fig. 7. Side effects at 6-months.

Published
2023
Full Text
View/download PDF

12. sj-docx-2-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-2-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

13. sj-docx-1-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-1-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

14. Additional file 3 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 3. TIDier Checklist.

Published
2023
Full Text
View/download PDF

15. People who make frequent emergency department visits based on persistence of frequent use in Ontario and Alberta: a retrospective cohort study

Author

Moe, Jessica, primary, Wang, Elle (Yuequiao), additional, McGregor, Margaret J., additional, Schull, Michael J., additional, Dong, Kathryn, additional, Holroyd, Brian R., additional, Hohl, Corinne M., additional, Grafstein, Eric, additional, O’Sullivan, Fiona, additional, Trimble, Johanna, additional, and McGrail, Kimberlyn M., additional

Published
2022
Full Text
View/download PDF

16. Subgroups of people who make frequent emergency department visits in Ontario and Alberta: a retrospective cohort study

Author

Moe, Jessica, primary, Wang, Elle (Yuequiao), additional, McGregor, Margaret J., additional, Schull, Michael J., additional, Dong, Kathryn, additional, Holroyd, Brian R., additional, Hohl, Corinne M., additional, Grafstein, Eric, additional, O’Sullivan, Fiona, additional, Trimble, Johanna, additional, and McGrail, Kimberlyn M., additional

Published
2022
Full Text
View/download PDF

17. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Agarwal, Gina, additional, Banh, Hoan Linh, additional, Dore Brown, Naomi, additional, Cassels, Alan, additional, Colwill, Kiska, additional, Dolovich, Lisa, additional, Farrell, Barbara, additional, Garrison, Scott, additional, Gillett, James, additional, Griffith, Lauren E., additional, Holbrook, Anne, additional, Jurcic-Vrataric, Jane, additional, McCormack, James, additional, O’Reilly, Daria, additional, Raina, Parminder, additional, Richardson, Julie, additional, Risdon, Cathy, additional, Savelli, Mat, additional, Sherifali, Diana, additional, Siu, Henry, additional, Tarride, Jean-Éric, additional, Trimble, Johanna, additional, Ali, Abbas, additional, Freeman, Karla, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Templeton, Jeffrey A., additional, Dragos, Steven, additional, Borhan, Sayem, additional, and Thabane, Lehana, additional

Published
2021
Full Text
View/download PDF

18. WHAT YOU NEED TO KNOW ABOUT ANTICHOLINERGIC MEDICATIONS.

Author

CURRIE, JANET and TRIMBLE, JOHANNA

Subjects
ANTIDEPRESSANTS, PARASYMPATHOMIMETIC agents, NONPRESCRIPTION drugs, ACETYLCHOLINE, INFORMATION resources, DEMENTIA, GENETIC techniques, MEDICAL prescriptions, DOSAGE forms of drugs, ANTIPSYCHOTIC agents, PHARMACODYNAMICS
Published
2023

25. Additional file 6 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 6. PDF. Site fidelity to TAPER-RCT model. The checklist that will be used to measure a site’s adherence to the TAPER-RCT protocol.

26. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

27. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

28. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

29. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan L., Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O���Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-��ric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Background Polypharmacy in older adults can be associated with negative outcomes including falls, impaired cognition, reduced quality of life, and general and functional decline. It is not clear to what extent these are reversible if the number of medications is reduced. Primary care does not have a systematic approach for reducing inappropriate polypharmacy, and there are few, if any, approaches that account for the patient���s priorities and preferences. The primary objective of this study is to test the effect of TAPER (Team Approach to Polypharmacy Evaluation and Reduction), a structured operationalized clinical pathway focused on reducing inappropriate polypharmacy. TAPER integrates evidence tools for identifying potentially inappropriate medications, tapering, and monitoring guidance and explicit elicitation of patient priorities and preferences. We aim to determine the effect of TAPER on the number of medications (primary outcome) and health-related outcomes associated with polypharmacy in older adults. Methods We designed a multi-center randomized controlled trial, with the lead implementation site in Hamilton, Ontario. Older adults aged 70 years or older who are on five or more medications will be eligible to participate. A total of 360 participants will be recruited. Participants will be assigned to either the control or intervention arm. The intervention involves a comprehensive multidisciplinary medication review by pharmacists and physicians in partnership with patients. This review will be focused on reducing medication burden, with the assumption that this will reduce the risks and harms of polypharmacy. The control group is a wait list, and control patients will be given appointments for the TAPER intervention at a date after the final outcome assessment. All patients will be followed up and outcomes measured in both groups at baseline and 6 months. Discussion Our trial is unique in its design in that it aims to introduce an operationalized structured clinical pathway aimed to reduce polypharmacy in a primary care setting while at the same time recording patient���s goals and priorities for treatment. Trial registration Clinical Trials.gov NCT02942927. First registered on October 24, 2016.

30. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

31. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

32. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

33. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

34. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

35. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

36. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

37. How's Your Health at Home: Frail Homebound Patients Reported Health Experience and Outcomes.

Author

McGregor MJ, Slater J, Sloan J, McGrail KM, Martin-Matthews A, Berg S, Plecash A, Sloss L, Trimble J, and Murphy JM

Subjects
Activities of Daily Living, Aged, Aged, 80 and over, Female, Health Status, Humans, Male, Middle Aged, Quality of Life, Self Report, Self-Management statistics & numerical data, Surveys and Questionnaires, Frail Elderly statistics & numerical data, Homebound Persons statistics & numerical data
Abstract

We used a web-based mixed methods survey (HowsYourHealth - Frail) to explore the health of frail older (78% age 80 or older) adults enrolled in a home-based primary care program in Vancouver, Canada. Sixty per cent of eligible respondents participated, representing over one quarter (92/350, 26.2%) of all individuals receiving the service. Despite high levels of co-morbidity and functional dependence, 50 per cent rated their health as good, very good, or excellent. Adjusted odds ratios for positive self-rated health were 7.50, 95 per cent CI [1.09, 51.81] and 4.85, 95 per cent CI [1.02, 22.95] for absence of bothersome symptoms and being able to talk to family or friends respectively. Narrative responses to questions about end of life and living with illness are also described. Results suggest that greater focus on symptom management, and supporting social contact, may improve frail seniors' health.

Published
2017
Full Text
View/download PDF

38. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.

Author

Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, and Silvius J

Subjects
Aged, Canada, Cooperative Behavior, Drug-Related Side Effects and Adverse Reactions prevention & control, Female, Health Care Reform economics, Health Care Reform methods, Humans, Male, Deprescriptions, Polypharmacy, Program Development methods
Abstract

Polypharmacy is growing in Canada, along with adverse drug events and drug-related costs. Part of the solution may be deprescribing, the planned and supervised process of dose reduction or stopping of medications that may be causing harm or are no longer providing benefit. Deprescribing can be a complex process, involving the intersection of patients, health care providers, and organizational and policy factors serving as enablers or barriers. This article describes the justification, theoretical foundation, and process for developing a Canadian Deprescribing Network (CaDeN), a network of individuals, organizations, and decision-makers committed to promoting the appropriate use of medications and non-pharmacological approaches to care, especially among older people in Canada. CaDeN will deploy multiple levels of action across multiple stakeholder groups simultaneously in an ecological approach to health system change. CaDeN proposes a unique model that might be applied both in national settings and for different transformational challenges in health care.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results